Prediction of survival in patients suffering from spinal metastases: a prospective, multicenter validation study.

ABSTRACT:

Background

The treatment of patients with symptomatic spinal metastasis is challenging, and it warrants a multi-disciplinary approach. When surgery is considered, the expected survival time at three months might be an important argument in the discussion. With the advent of new treatment modalities, however, validation of an existing prediction model is warranted.

Methods

Validation study with inclusion of patients after informed consent from May 2021 through December 2023 in one academic hospital and two large non-academic medical centers. Information was collected on the following variables: sex, primary tumor type, treatment of the primary tumor with curative intention, cervical location of the metastasis, and the highest Karnofsky Performance Score in 24 hours before pre

SUBMITTER: Bartels RHMA 

PROVIDER: S-EPMC12611296 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature